Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-01-24
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, it's important to note that we don't yet fully understand the best way to provide breathing support for long-term NIV users, like COPD and OHS patients. The understanding of breathing route is currently only established for OSA. However, conditions like COPD affect the lungs and the overall system used for breathing, which is different from the throat blockage seen in OSA. So, the assumptions we make based on conditions like OSA may not apply to these other conditions. More research is needed to understand this better.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Mask Design on Ventilation Parameters in COPD and OHS Patients on Long-term Home Non-invasive Ventilation. An Experimental Study.
NCT06972589
Efficacy of NIV Masks in COPD
NCT04947852
Respiratory Drive Response in COPD Patients During Exercise With Non Invasive Ventilation (NIV).
NCT04597606
FiO2 in Chronic Obstructive Pulmonary Disease (COPD) Patient Normobaric O2 Versus NIV
NCT02599246
Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )Patients
NCT00114426
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The participants are then put on their prescribed airway pressure support with the first randomized mask, and their breathing is recorded again for 30 minutes.
* The mask is switched to the second mask, and the same procedure is repeated.
Participants are then moved to the sleep laboratory for the night where they are provided with beds.
* They continue NIV therapy with the last mask used during the awake test.
* After at least 60 minutes of recording, participants are awakened to switch back to the first mask. They are then allowed to sleep uninterrupted for the rest of the night.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathing route assessment: Awake and off pressure support
Breathing route will be recorded in awake participants without the use of NIV for approximately 30 min.
No interventions assigned to this group
Breathing route assessment: Awake and on pressure support
Awake participants will be placed on their prescribed pressure support settings and will use two different non-invasive ventilation (NIV) masks, each for about 30 minutes.
NIV mask A
Bridge free face mask
NIV mask B
Full face mask
Breathing route assessment: Asleep and on pressure support
Participants will be placed on their prescribed pressure support settings and will go to sleep. After 60 minutes, they will be awakened to change their mask. They will use two different non-invasive ventilation (NIV) masks, each for a minimum of 60 minutes
NIV mask A
Bridge free face mask
NIV mask B
Full face mask
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NIV mask A
Bridge free face mask
NIV mask B
Full face mask
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescribed nocturnal NIV for COPD or OHS
* Able to complete an overnight sleep study
* Comfortable to sleep on a standard double bed
* Capacity to complete informed consent
Exclusion Criteria
* Prescribed IPAP above 25 cmH2O
* Self-reported pregnancy
* Allergic to adhesive of the sensors
* Self-reported cold/flu symptoms
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fisher and Paykel Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Good, Medical degree
Role: PRINCIPAL_INVESTIGATOR
Middlemore Hospital, New Zealand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fisher and Paykel Healthcare Sleep Laboratory
Auckland, , New Zealand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1308-1838
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.